Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory B Cell Acute Lymphoblastic Leukemia (ALL)”

886 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 886 results

Early research (Phase 1)Not Yet RecruitingNCT04595162
What this trial is testing

GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Peking University Third Hospital 12
Large-scale testing (Phase 3)Study completedNCT03123939
What this trial is testing

Phase III B in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Looking for participantsNCT06179524
What this trial is testing

CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL

Who this might be right for
Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Beijing Yongtai Ruike Biotechnology Company Ltd 100
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00006042
What this trial is testing

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT00313053
What this trial is testing

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Clare Twist 4
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT01129193
What this trial is testing

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more
Amir Mortazavi 44
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Early research (Phase 1)Ended earlyNCT02231853
What this trial is testing

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Who this might be right for
Chronic Lymphocytic LeukemiaCML (Chronic Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 12
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Testing effectiveness (Phase 2)UnknownNCT01279707
What this trial is testing

Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)

Who this might be right for
Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia
Queen Mary University of London 55
Testing effectiveness (Phase 2)Study completedNCT00082888
What this trial is testing

Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueMature T-Cell and NK-Cell Non-Hodgkin Lymphoma+10 more
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Ended earlyNCT01419795
What this trial is testing

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Fred Hutchinson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05255601
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
Bristol-Myers Squibb 68
Very early researchUnknownNCT05480501
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd. 9
Load More Results